Andrew Cooley is a seasoned professional in the pharmaceutical industry, currently serving as a Disease Area Leader in Oncology Global Pharma Strategy at Genentech. Previously, Cooley held various positions at Genentech from 2015 to 2018, including Pipeline & Portfolio Planning Hematology Franchise Lead and Senior Disease Area Director for Oncology Global Product Strategy. Cooley also contributed to Perseid Therapeutics as a Process Development Associate II and gained early experience at Amgen as a Manufacturing Associate. Cooley earned a Bachelor of Science in Chemical Engineering with a minor in Biomedical Engineering from Cornell University and an MBA in Health Enterprise Management, Finance, and Marketing from Northwestern University's Kellogg School of Management.
This person is not in the org chart
This person is not in any teams
This person is not in any offices